Supernus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $47.69 |
Previous Close | $48.04 |
Day Range | $47.42-$48.21 |
52W Range | $29.16-$48.44 |
Market Cap | $2.6B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $665.1M |
Revenue Growth (YoY) | -1.7% |
Gross Profit (12 Mos) | $588.8M |
Diluted EPS | $1.17 |
News
See moreYahoo Finance • 15 days ago
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Yahoo Finance • 24 days ago
SUPERNUS PHARMACEUTICALS INC (NASDAQ:SUPN) Emerges as a Top Affordable Growth Stock
Yahoo Finance • last month
Supernus Pharmaceuticals to Participate in September Investor Conferences
Yahoo Finance • 2 months ago
Here’s Third Avenue Small-Cap Value Fund’s Update on Supernus Pharmaceuticals (SUPN)
About
CEO | Mr. Jack A. Khattar M.B.A. |
CFO | Mr. Timothy C. Dec |
Address | 9715 Key West Avenue, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 674 |
